FDA Flu Vaccine Inspections Need More Compressed Timeframe – Rep. Davis

FDA's procedures for inspecting flu vaccine manufacturing facilities may need revision in light of the current supply shortage, House Government Reform Committee Chairman Tom Davis (R-Va.) suggested during a Nov. 17 hearing